The launch was based on the completion of clinical evaluation of EasyCell analyzer at Boston Children’s Hospital, which confirmed the instrument’s efficacy in the hematology laboratory environment.
The EasyCell analyzer automates and simplifies the cell differential process by locating and preclassifying white blood cells.
Boston Children’s Hospital medical technologist Kyle Riding said the EasyCell assistant’s cell pre-classification enhanced the company’s technologists’ confidence in their analyses.
"In addition, the instrument was highly reliable, easy to learn and maintain, and fit well in the laboratory’s workflow," Riding added.
"You are able to get results faster and in a more consistent manner, which should result in better and faster patient diagnoses."
Medica business development vice president Doug Moe said the EasyCell assistant lowers cost by substantially cutting the time technologists require to perform manual blood cell differentials and correctly classify normal cells.
"It enables the technologist to quickly review the suggested classifications and then devote more time to the analysis of abnormal cells," Moe added.